Assignee
WOOLSEY PHARMACEUTICALS INC
US·11 granted patents·21 pending applications·12 citations·filing 2021–2025
Top patents by PatentIndex Score
32 records- 0195US11311553B1Methods of treating 4-repeat tauopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·5 cites·18 claims
- 0294US11771704B1Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 3, 2023·1 cites·13 claims
- 0394US11642352B2Methods of treating wandering in Lewy dody dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·3 cites·12 claims
- 0491US11865119B2Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Jan 9, 2024·1 cites·27 claims
- 0589US11944633B2Oral formulations of fasudil with ion exchange resinWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Apr 2, 2024·1 cites·25 claims
- 0687US11666583B2Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·1 cites·15 claims
- 0782US12290522B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·0 cites·22 claims
- 0879US2024100064A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0978US12115167B2Oral formulations of fasudil with ion exchange resinWOOLSEY PHARMACEUTICALS INC·Filed 2024·Granted Oct 15, 2024·0 cites·23 claims
- 1076US11779588B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Oct 10, 2023·0 cites·16 claims
- 1175US2025268911A1Methods of Using RHO Kinase Inhibitors to Treat Alzheimer's DiseaseWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1273US12329761B2Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 17, 2025·0 cites·12 claims
- 1373US2025228868A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1472US2023248739A1Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1572US2023226073A1Methods of treating proteinopathy associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1670US2022047607A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1768US2024299410A1Methods of treating familial amyotrophic lateral sclerosis by oral administration of fasudilWOOLSEY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1868US2024423998A1Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1967US2021401853A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2065US2026014167A1Treating Amyotrophic Lateral Sclerosis Having Onset 24 Months Prior to TreatmentWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2165US2025381197A1Regimen for Treating Amyotrophic Lateral Sclerosis Having Onset 24 Months Prior to TreatmentWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2261US12128053B2Taste-masking oral formulations of fasudilWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·8 claims
- 2361US2024415846A1Method of treating amyotrophic lateral sclerosis and dosing regimen for sameWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2461US2024261298A1Methods of treating depression and anxietyWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2561US2024252511A1Methods of treating depression and anxietyWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2658US2024423997A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2754US2023080958A1Methods of treating pseudobulbar affect and other emotional disturbancesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2854US2023263806A1Methods of treating proteinopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2954US2023285409A1Methods of using rho kinase inhibitors to treat vascular dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3054US2023321114A1Methods of treating age-related cognitive declineWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3154US2023405017A1Methods of using rho kinase inhibitors to treat frontotemporal dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3253US2023310447A1Methods of treating age-related cognitive declineWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WOOLSEY PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →